PhaRmacOgenetics and Therapeutic Drug Monitoring In SchizophrEnia

NCT05839613 · clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
400
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Assistance Publique Hopitaux De Marseille